Skip to main content
. Author manuscript; available in PMC: 2019 Apr 30.
Published in final edited form as: Infect Control Hosp Epidemiol. 2016 Dec 6;38(3):314–319. doi: 10.1017/ice.2016.265

TABLE 1.

Demographic and Clinical Characteristics and Healthcare Exposures of 12 Pantoea agglomerans Case Patients at Clinic A in Illinois, 2012-2013

Characteristic Value
Demographic characteristics
 Female sex 7 (58)
 Age, median (range), y 65 (41–78)
Clinical characteristics
 Diagnosis of malignant tumor 12 (100)
  Solid organ 9 (75)
  Hematologic 3 (25)
 Presence of central line (ie, implanted port) 11 (92)
  Time central line in place at time of positive culture, median (range), months 4 (2–30)
 Documented fever (temperature ≥100.4°F) within 48 hours of first positive culture 11 (92)
 Chills or rigors during presentation 10 (83)
 Blood culture positive for P. agglomerans infectiona 12 (100)
 Hospitalized for P. agglomerans infection 9 (75)
 Treated with antibiotics 11 (92)
 Central line removed 7/11 (64)
 Death within 30 days of initial culture 0 (0)
Healthcare exposuresb
 Any infusion product (excluding saline or heparin flush) 12 (100)
  Chemotherapy infusion (prepared at clinic A) 11 (92)
  Blood transfusion 2 (17)
 Receipt of heparin flush 11 (92)
 Receipt of normal saline flush 12 (100)
 Number of infusion visits, median (range) 2 (0–8)
 Time since most recent chemotherapy infusion, median (range), days 14 (0–54)

note. Data are no. (%) of case-patients, unless otherwise indicated.

a

One patient also had a positive catheter tip culture for P. agglomerans.

b

Occurring within 3 weeks or 3 infusion visits prior to the date of the first positive Pantoea culture.